Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Added Sugar, Sugar-Sweetened Beverages, and Artificially Sweetened Beverages and Risk of Cardiovascular Disease: Findings from the Women's Health Initiative and a Network Meta-Analysis of Prospective Studies.
Yang B, Glenn AJ, Liu Q, Madsen T, Allison MA, Shikany JM, Manson JE, Chan KHK, Wu WC, Li J, Liu S, Lo K. Yang B, et al. Among authors: wu wc. Nutrients. 2022 Oct 11;14(20):4226. doi: 10.3390/nu14204226. Nutrients. 2022. PMID: 36296910 Free PMC article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure.
Patel SS, Raman VK, Zhang S, Deedwania P, Zeng-Treitler Q, Wu WC, Lam PH, Bakris G, Moore H, Heidenreich PA, Rangaswami J, Morgan CJ, Cheng Y, Sheriff HM, Faselis C, Mehta RL, Anker SD, Fonarow GC, Ahmed A. Patel SS, et al. Among authors: wu wc. Eur J Heart Fail. 2024 May;26(5):1251-1260. doi: 10.1002/ejhf.3210. Epub 2024 May 3. Eur J Heart Fail. 2024. PMID: 38700246
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
Patel S, Lam PH, Kanonidis EI, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A. Patel S, et al. Among authors: wu wc. Am J Med. 2023 Jul;136(7):677-686. doi: 10.1016/j.amjmed.2023.03.017. Epub 2023 Apr 3. Am J Med. 2023. PMID: 37019372 Free PMC article.
Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF.
Sin MK, Allman RM, Faselis C, Aronow WS, Brown CJ, Lam PH, Wu WC, Zeng-Treitler Q, Patel SS, Raman VK, Zhang S, Sheriff HM, Morgan CJ, Heidenreich PA, Fonarow GC, Ahmed A. Sin MK, et al. Among authors: wu wc. Am J Med. 2024 Nov 12:S0002-9343(24)00710-1. doi: 10.1016/j.amjmed.2024.10.019. Online ahead of print. Am J Med. 2024. PMID: 39551174
Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure.
Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A. Lam PH, et al. Among authors: wu wc. Am J Med. 2024 Oct 17:S0002-9343(24)00638-7. doi: 10.1016/j.amjmed.2024.10.015. Online ahead of print. Am J Med. 2024. PMID: 39424217
1,418 results